IL6 and type 2 diabetes mellitus: Male Wistar rats, fed with a high-fat diet and treated with a low dose of STZ (30–40 mg/ kg body weight) is reported to be a reliable model for human type 2 diabetes symptoms, which include peripheral insulin resistance, increased plasma interleukin-6 (IL-6) and hyperglycemia [13,14].